MedMen: what went wrong at the cannabis industry’s first unicorn, with Founder and former CEO Adam Bierman
On the outside it looked like Adam Bierman had it all. He was the Co-Founder and CEO of MedMen, a cult phenomenon and the world’s first cannabis unicorn. They were seen as the Apple of weed and they looked unstoppable.
Audio is streamed directly from the publisher (chtbl.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Look, we’re going to tell you straight - this is a blinding episode - and that’s because we’re talking to a man who is unflinchingly honest about his Founder experience.
On the outside it looked like Adam Bierman had it all. He was the Co-Founder and CEO of MedMen, a cult phenomenon and the world’s first cannabis unicorn. They were seen as the Apple of weed and they looked unstoppable.
But in 2019, a year after hitting its all time high on the Canadian stock market, the company had lost 95% of its value. Adam’s personal wealth was also up in smoke because he hadn’t listened to his advisors - instead of diversifying his assets, he’d bought even more MedMen stock. And then came the lawsuits.
Adam is no longer with the company and was in a reflective mood when he sat down with Dan.
So what on earth happened? Why did he leave the company? And what has he learnt from all of this?
--
Sponsors
Vorboss - get better internet: https://vorboss.com/secretleaders
Vanta - get 20% off security certifications like ISO27001 and SOC2: https://vanta.com/secretleaders
Vertice - save on your SaaS or cloud spend ($5k off or a free benchmark) using the code secretleaders: https://www.vertice.one/l/secretleaders
--
Newsletter
Sign up here: https://secretleaders.email/
You can find our historic newsletters here: https://www.secretleaders.com/episodes